Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

15.81 -0.40 (-2.47%)
Streaming Delayed Price Updated: 2:55 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about RxSight, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Deep Dive Into RxSight Stock: Analyst Perspectives (12 Ratings)
Via Benzinga
What's going on in today's session
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements. 
Via Chartmill
RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations
RxSight revised its FY25 revenue outlook below estimates, with Q1 sales lagging expectations. BofA downgraded the stock, citing slowing growth and risks ahead. 
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Expert Outlook: RxSight Through The Eyes Of 11 Analysts
Via Benzinga
Earnings Scheduled For February 25, 2025
Via Benzinga
Forecasting The Future: 4 Analyst Projections For RxSight
Via Benzinga
11 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Thursday's session.
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Analyst Scoreboard: 7 Ratings For RxSight
Via Benzinga
Peeling Back The Layers: Exploring RxSight Through Analyst Insights
Via Benzinga
Deep Dive Into RxSight Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
RxSight Analysts Slash Their Forecasts After Q2 Results
Via Benzinga
Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall
Via Benzinga
Topics Stocks
Exposures US Equities
RH Posts Downbeat Earnings, Joins Apple, Tesla, Nvidia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges
RxSight shares down premarket on revised FY25 outlook. CEO cites headwinds in premium IOL market and economy. 
Via Benzinga
RXST Stock Earnings: RxSight Beats Revenue for Q2 2024
RXST stock results show that RxSight beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
The Analyst Verdict: RxSight In The Eyes Of 9 Experts
Via Benzinga
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
RxSight Stock Sees Relative Strength Rating Rise To 91
On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91. 
Via Investor's Business Daily
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday! 
Via InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
The 3 Best Med Tech Stocks to Buy Now
Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now. 
Via InvestorPlace
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2? 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.